ZYDUS PHARMS USA INC FDA Approval ANDA 078385

ANDA 078385

ZYDUS PHARMS USA INC

FDA Drug Application

Application #078385

Application Sponsors

ANDA 078385ZYDUS PHARMS USA INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL12.5MG;50MG0LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
002TABLET;ORAL25MG;100MG0LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

FDA Submissions

ORIG1AP2010-10-06
LABELING; LabelingSUPPL6AP2011-09-21
LABELING; LabelingSUPPL7AP2013-01-28
LABELING; LabelingSUPPL8AP2013-03-08
LABELING; LabelingSUPPL9AP2013-02-20STANDARD
LABELING; LabelingSUPPL10AP2013-11-06STANDARD
LABELING; LabelingSUPPL11AP2014-08-15STANDARD
LABELING; LabelingSUPPL14AP2015-10-06STANDARD
LABELING; LabelingSUPPL16AP2016-07-15STANDARD
LABELING; LabelingSUPPL17AP2019-07-08STANDARD
LABELING; LabelingSUPPL18AP2020-02-24STANDARD

Submissions Property Types

ORIG1Null7
SUPPL6Null15
SUPPL7Null7
SUPPL8Null15
SUPPL9Null15
SUPPL10Null15
SUPPL11Null7
SUPPL14Null15
SUPPL16Null15
SUPPL17Null7
SUPPL18Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78385
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM","strength":"12.5MG;50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM","strength":"25MG;100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM","actionType":"12.5MG;50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM","actionType":"25MG;100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.